These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 9294616)

  • 1. Induction of ornithine decarboxylase by IL-3 is mediated by sequential c-Myc-independent and c-Myc-dependent pathways.
    Packham G; Cleveland JL
    Oncogene; 1997 Sep; 15(10):1219-32. PubMed ID: 9294616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of human ornithine decarboxylase expression following prolonged quiescence: role for the c-Myc/Max protein complex.
    Peña A; Wu S; Hickok NJ; Soprano DR; Soprano KJ
    J Cell Physiol; 1995 Feb; 162(2):234-45. PubMed ID: 7822433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Myc and Max transregulate the mouse ornithine decarboxylase promoter through interaction with two downstream CACGTG motifs.
    Tobias KE; Shor J; Kahana C
    Oncogene; 1995 Nov; 11(9):1721-7. PubMed ID: 7478599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of c-myc and ornithine decarboxylase expression by distinct protein kinase systems in IL-3-dependent myeloid cells.
    Farrar WL; Willette-Brown J; Linnekin D
    Lymphokine Cytokine Res; 1991 Aug; 10(4):291-9. PubMed ID: 1718453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-Myc induces apoptosis and cell cycle progression by separable, yet overlapping, pathways.
    Packham G; Porter CW; Cleveland JL
    Oncogene; 1996 Aug; 13(3):461-9. PubMed ID: 8760287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. hnRNP U interacts with the c-Myc-Max complex on the E-box promoter region inducing the ornithine decarboxylase gene.
    Matsuoka Y; Uehara N; Tsubura A
    Oncol Rep; 2009 Aug; 22(2):249-55. PubMed ID: 19578763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-Myc induces the expression and activity of ornithine decarboxylase.
    Wagner AJ; Meyers C; Laimins LA; Hay N
    Cell Growth Differ; 1993 Nov; 4(11):879-83. PubMed ID: 8297793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Position and orientation independent transactivation by c-Myc.
    Packham G; Bello-Fernandez C; Cleveland JL
    Cell Mol Biol Res; 1994; 40(7-8):699-706. PubMed ID: 7787888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour promoter mediated altered expression and regulation of ornithine decarboxylase and S-adenosylmethionine decarboxylase in H-ras-transformed fibrosarcoma cell lines.
    Voskas D; Mader R; Lee J; Hurta RA
    Biochem Cell Biol; 2001; 79(1):69-81. PubMed ID: 11235918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transformation by H-ras can result in aberrant regulation of ornithine decarboxylase gene expression by transforming growth factor-beta(1).
    Hurta RA; Lee J; Voskas D
    J Cell Biochem; 2001; 81(1):39-55. PubMed ID: 11180396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis.
    Askew DS; Ashmun RA; Simmons BC; Cleveland JL
    Oncogene; 1991 Oct; 6(10):1915-22. PubMed ID: 1923514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APC-dependent regulation of ornithine decarboxylase in human colon tumor cells.
    Fultz KE; Gerner EW
    Mol Carcinog; 2002 May; 34(1):10-8. PubMed ID: 12112318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-7 regulates c-myc expression in murine T cells and thymocytes: a role for tyrosine kinase(s) and calcium mobilization.
    Seckinger P; Milili M; Schiff C; Fougereau M
    Eur J Immunol; 1994 Mar; 24(3):716-22. PubMed ID: 7510242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role for protein kinase C-delta in the regulation of ornithine decarboxylase expression by oxidative stress.
    Otieno MA; Kensler TW
    Cancer Res; 2000 Aug; 60(16):4391-6. PubMed ID: 10969783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor promoter-induced ornithine decarboxylase gene expression occurs independently of AP-1 activation.
    Jansen AP; Colburn NH; Verma AK
    Oncogene; 1999 Oct; 18(42):5806-13. PubMed ID: 10523861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-IgM-induced growth inhibition and apoptosis are independent of ornithine decarboxylase in Ramos cells.
    Lin CK; Zou HY; Kaptein JS; Yen CF; Kalunta CI; Nguyen TT; Park E; Lad PM
    Exp Cell Res; 1997 Nov; 237(1):231-41. PubMed ID: 9417887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Na + flux inhibitors on induction of c-fos, c-myc, and ODC genes during cell cycle.
    Panet R; Amir I; Snyder D; Zonenshein L; Atlan H; Laskov R; Panet A
    J Cell Physiol; 1989 Jul; 140(1):161-8. PubMed ID: 2472417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation.
    Nilsson JA; Keller UB; Baudino TA; Yang C; Norton S; Old JA; Nilsson LM; Neale G; Kramer DL; Porter CW; Cleveland JL
    Cancer Cell; 2005 May; 7(5):433-44. PubMed ID: 15894264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ornithine decarboxylase is a transcriptional target of tumor suppressor WT1.
    Li RS; Law GL; Seifert RA; Romaniuk PJ; Morris DR
    Exp Cell Res; 1999 Feb; 247(1):257-66. PubMed ID: 10047468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced p21WAF1 expression acts to reverse myc myelomonocytic cell transformation.
    Dolnikov A; Millington M; Sun LQ; Symonds G
    Cancer Gene Ther; 2000 Nov; 7(11):1491-503. PubMed ID: 11129291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.